An unfortunate aspect of our legal system is that many important legal issues are not resolved by the courts because a controversy is not only too big to try, but also too big to be filed. A good example is federal-government-threatened civil and criminal claims against pharmaceutical manufacturers for "off-label" promotion, i.e., promotion of pharmaceutical products for uses other than those described on their FDA-approved labeling.
Health Care Law
Caronia: A Serious First Amendment Rebuke to Federal Off-Label Marketing Prosecutions
The Legal Intelligencer
January 15, 2013
This article requires premium access
This article requires premium access to The Legal Intelligencer. Please sign in or subscribe to read the full text.